EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update

Vasvi Bhutani, Fahimeh Varzideh, Scott Wilson iD, Urna Kansakar, Stanislovas S Jankauskas, Gaetano Santulli iD

Journal of Cardiovascular Development and Disease · 30.05.2025 · 12 (6) · 207

DOI: 10.3390/jcdd12060207 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 30.05.2025. Verfasst von Vasvi Bhutani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Division of Cardiology), Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstei…. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin is an anthracycline chemotherapeutic that is widely used for treating various malignancies, including breast cancer, lymphomas, and sarcomas. Despite its efficacy, its clinical utility is limited by a well-documented risk of cardiotoxicity, which may manifest acutely or chronically. Doxorubicin works by intercalating DNA and inhibiting topoisomerase II, leading to DNA damage and cell death. However, this mechanism is not selective to cancer cells and can adversely affect cardiac myocytes. The introduction of doxorubicin into oncologic practice has revolutionized cancer treatment, but its cardiotoxic effects remain a significant concern. This systematic review aims to comprehensively examine the multifaceted impact of doxorubicin on cardiac structure and function through both preclinical and clinical lenses.

Schlagwörter

Stichwörter der Autor:innen

DNA damageanthracyclinescardiomyopathycell deathdoxorubicinheart failureoncology

Autor:innen und Institutionen

  • Department of Medicine (Division of Cardiology), Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, New York City, NY 10461, USA.
  • International Translational Research and Medical Education (ITME) Consortium, Academic Research Unit, Department of Advanced Biomedical Sciences, "Federico II" University, 80131 Naples, Italy.
  • Department of Molecular Pharmacology, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Alber…

ORCID-Profile: Scott Wilson, Gaetano Santulli

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • National Institutes of Health (NIH): National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Center for Advancing Translational Sciences
  • American Heart Association

Zitieren

APA

Bhutani, V., Varzideh, F., Wilson, S., Kansakar, U., Jankauskas, S. S., & Santulli, G. (2025). Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update. Journal of Cardiovascular Development and Disease, 12(6), 207. https://doi.org/10.3390/jcdd12060207

Vancouver

Bhutani V, Varzideh F, Wilson S, Kansakar U, Jankauskas SS, Santulli G. Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update. Journal of Cardiovascular Development and Disease. 2025;12(6):207. doi:10.3390/jcdd12060207

BibTeX
@article{Bhutani2025,
  author = {Bhutani, Vasvi and Varzideh, Fahimeh and Wilson, Scott and Kansakar, Urna and Jankauskas, Stanislovas S and Santulli, Gaetano},
  title = {Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2025},
  volume = {12},
  number = {6},
  pages = {207},
  doi = {10.3390/jcdd12060207}
}
Kostenlos starten →